offenders

Justice-involved individuals with substance use problems have heightened risk of relapse and recidivism after release from incarceration, making reentry a critical time to provide evidence-based treatments (EBTs) for substance use; however...

See this message as a web page: WHY IS THE RECORD SO POOR? The first cell of row 5 presented a catalogue of negative evaluations of attempts to treat problem drinking among sentenced offenders in Britain, a record also seen internationally...

View this message as a web page BEYOND THE PATIENT: TREATMENT’S IMPACTS ON FAMILY AND COMMUNITY Time to consolidate the lessons of row 5 of the Alcohol Treatment Matrix. This final row defocused from the patient to ask what treatment can do...

CARE AND CONTROL: HOW FAR SHOULD COLLABORATION GO? Key review argues that criminal justice and treatment conducted in a criminal justice context should see themselves as partners in a common effort, but one is geared to protecting society...

CRIMINAL JUSTICE THERAPY: MELDING CARE WITH CONTROL In theory the great advantage of treatment ordered by the criminal justice system is that it can ‘hold’ patients in treatment and get them to comply with the programme sufficiently to gain...

ORGANISATIONS SET THE CONTEXT FOR CRIME-REDUCING TREATMENT Key studies teasing out organisational-level influences on treatment for drinking problems which aims to reduce crime and safeguard family and community. In the context of a market...

MANAGING TO EXTRACT THERAPY FROM PUNISHMENT Key studies on the role of management in the treatment of problem drinking in criminal justice settings and/or to safeguard the community. A rare review specific to this context argues that “the...

At issue was whether by referring heroin users to treatment, probation services in England would protect them from fatal overdose and prevent drug-related crime. Yes to one, but not the other, were the answers; unexpectedly, crime went up...

Opinion is sharply divided on the ethics and effectiveness of pressuring opioid-dependent offenders to take the opiate-blocker naltrexone. Especially sharp is the controversy over long-acting products not approved for medical use in the UK...